{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:33:35Z","timestamp":1785321215408,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.vaccine.2013.03.045","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T05:16:21Z","timestamp":1386652581000},"page":"J15-J20","source":"Crossref","is-referenced-by-count":45,"special_numbering":"S9","title":["The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization"],"prefix":"10.1016","volume":"31","author":[{"given":"M.A.","family":"Kane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Hadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.N.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.03.045_bib0005","series-title":"Sustainability of achievements: lessons learned from universal childhood immunization. Report of a Steering Committee","author":"UNICEF","year":"1996"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0010","unstructured":"Melgaard B. Immunization and health reform: the implications of decentralisation. Paper presented to the Scientific Advisory Group of Experts (SAGE), Geneva, 9\u201311 June 1998. Document reference GPV-CVI\/SAGE.98\/WP.13. Geneva: World Health Organization; 1998."},{"key":"10.1016\/j.vaccine.2013.03.045_bib0015","series-title":"Should all vertical programs just lie down?","author":"Levine","year":"2007"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0020","series-title":"Horizontal and vertical delivery of health services: what are the trade offs?","author":"Msuya","year":"2005"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0025","series-title":"Origins of GAVI","author":"GAVI","year":"2012"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0030","series-title":"National review on national immunization programme in 2004","author":"MOH","year":"2005"},{"issue":"1","key":"10.1016\/j.vaccine.2013.03.045_bib0035","doi-asserted-by":"crossref","first-page":"J39","DOI":"10.1086\/599332","article-title":"Evaluation of the impact of hepatitis B vaccination among children born during 1992\u20132005 in China","volume":"200","author":"Liang","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0040","doi-asserted-by":"crossref","first-page":"J36","DOI":"10.1016\/j.vaccine.2012.11.061","article-title":"Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation","volume":"31","author":"Cui","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0045","doi-asserted-by":"crossref","first-page":"J29","DOI":"10.1016\/j.vaccine.2012.07.048","article-title":"Preventing hepatitits B through universal vaccination: reduction of inequalities through the China GAVI Project","volume":"31","author":"Cui","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0050","doi-asserted-by":"crossref","first-page":"J8","DOI":"10.1016\/j.vaccine.2012.12.019","article-title":"Origins, design and implementation of the China GAVI project","volume":"31","author":"Liang","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0055","unstructured":"WHO. Hepatitis B. Fact sheet N\u00b0 204 July 2012. http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/ (accessed 13.08.12)."},{"key":"10.1016\/j.vaccine.2013.03.045_bib0060","series-title":"The moral corporation: Merck experiences","author":"Vagelos","year":"2006"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0065","unstructured":"WHO. A system for the prequalification of vaccines for UN supply. http:\/\/www.who.int\/immunization_standards\/vaccine_quality\/pq_system\/en\/index.html (accessed 27.09.12)."},{"key":"10.1016\/j.vaccine.2013.03.045_bib0070","series-title":"International Review of the Expanded Programme on Immunizations in China","author":"World Health Organization China","year":"2004-2005"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0075","series-title":"Practice and policies on user fees for immunization in developing countries. WHO\/V&B\/01.07","author":"England","year":"2001"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0080","article-title":"The impact of SARS on China","author":"Xu","year":"2003","journal-title":"Seton Hall Journal of Diplomacy and International Relations"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0085","first-page":"1","article-title":"Evaluation of the hepatitis B model immunization program in Long\u2019an County, China","volume":"1","author":"Wang","year":"1995","journal-title":"J Guangxi Prev Med (Chin)"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0090","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2471\/BLT.06.037002","article-title":"Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy","volume":"85","author":"Wang","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0095","series-title":"Preventing mother-to child transmission of hepatitis B. Operational field guidelines for delivery of the birth dose of hepatitis B vaccine","author":"World Health Organization Regional Office for the Western Pacific","year":"2006"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0100","first-page":"CD004790","article-title":"Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers","volume":"2","author":"Lee","year":"2006","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1471-2334-12-221","article-title":"Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China","volume":"12","author":"Hu","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2013.03.045_bib0110","first-page":"789","article-title":"Unsafe injections in the developing world and transmission of bloodborne pathogens: a review","volume":"77","author":"Simonsen","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0115","series-title":"Evaluation of GAVI's injection safety support","author":"Levin","year":"2008"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0130","doi-asserted-by":"crossref","first-page":"J43","DOI":"10.1016\/j.vaccine.2012.11.057","article-title":"Evaluation of immunization injection safety in China, 2010: achievements, future sustainability","volume":"31","author":"Wu","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.045_bib0125","unstructured":"European Association for the Study of the Liver. Revised Clinical Practice Guidelines on the Management of Chronic Hepatitis B. Issue 8 (April 2012). http:\/\/www.easl.eu\/_clinical-practice-guideline\/issue-8-april-2012-revised-clinical-practice-guidelines-on-the-management-of-chronic-hepatitis-B (accessed 17.08.12)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13003824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13003824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T08:27:25Z","timestamp":1538987245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13003824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":25,"alternative-id":["S0264410X13003824"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.03.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}